Laddar...
Two hits are better than one: synergistic anticancer activity of α-helical peptides and doxorubicin/epirubicin
This study explored combinational anticancer therapy using α-helical peptides HPRP-A1/HPRP-A2 with the chemical drugs doxorubicin (DOX) and epirubicin (EPI). The in vitro activity of these drugs against different cancer cell lines was synergistically increased, as was their activity in a HeLa xenogr...
Sparad:
| I publikationen: | Oncotarget |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Impact Journals LLC
2014
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4359330/ https://ncbi.nlm.nih.gov/pubmed/25593197 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|